会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 63. 发明授权
    • Magnet system extrusion coating for a relay
    • 用于继电器的磁体系统挤压涂层
    • US08035468B2
    • 2011-10-11
    • US10535052
    • 2003-11-06
    • Ralf HoffmannHeinz Stadler
    • Ralf HoffmannHeinz Stadler
    • H01H67/02
    • H01H50/042H01H49/00H01H50/26H01H50/36
    • A relay has a magnet system with a core partially enclosed by a coil. A yoke has a first yoke leg attached to a first end of the core and a second yoke leg extending parallel to the core. The second yoke leg has an armature mounting portion formed on an upper side of the second yoke leg remote from the coil. A pole has a first pole leg connected to a second end of the core and a second pole leg extending parallel to the core. The second pole leg has an upper surface substantially aligned with the armature mounting portion. A fixed contact is arranged on a fixed contact carrier substantially aligned with the second pole leg. The arrangement of the magnet system ensures precise positional alignment during extrusion coating with a plastic material.
    • 继电器具有磁体系统,其中芯部被线圈部分地包围。 轭具有附接到芯的第一端的第一轭腿和平行于芯延伸的第二轭腿。 第二轭腿具有形成在远离线圈的第二轭腿的上侧上的电枢安装部分。 杆具有连接到芯的第二端的第一极腿和平行于芯延伸的第二极腿。 第二极腿具有与电枢安装部分大致对准的上表面。 固定触点布置在基本上与第二极腿对齐的固定触点支架上。 磁体系统的布置确保了在用塑料材料的挤出涂覆期间精确的位置对准。
    • 64. 发明授权
    • Substituted imidazo [1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives
    • 取代的咪唑并[1,5-a] [1,2,4]三唑并[1,5-d] [1,4]苯并二氮杂衍生物
    • US07671048B2
    • 2010-03-02
    • US11245736
    • 2005-10-07
    • Henner KnustHeinz StadlerAndrew William Thomas
    • Henner KnustHeinz StadlerAndrew William Thomas
    • A61P25/28A61K31/5517C07D487/12
    • A61K31/5517C07D487/14
    • The present invention is concerned with a method of treating a disease selected from the group consisting of cognitive disorders, anxiety, Alzheimer's disease, and schizophrenia comprising administering a therapeutically effective amount of a substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives of the following formula wherein R1 is halogen, lower alkyl, lower alkynyl, cycloalkyl, lower alkoxy, OCF3, —NHR, —NHC(O)R or —NHSO2R; R2 is hydrogen, methyl or aryl which is unsubstituted or substituted by one or two substituents selected from the group consisting of halogen and lower alkoxy; R3 is hydrogen, lower alkyl, lower alkenyl, cycloalkyl, lower alkoxy, —O(CH2)n+1—O-lower alkyl, —(CH2)n-aryl which is optionally substituted by lower alkyl or halogen, heteroaryl, —NHR, —N(R)2, wherein each R can be the same or different, —NHCH2C≡CH, or pyrrolidin-1-one; R is hydrogen, lower alkyl, lower alkyl substituted by halogen, heteroaryl, —(CH2)nO-lower alkyl, —NH-lower alkyl, cycloalkyl or aryl, and n is 0, 1, 2 or 3; and with their pharmaceutically acceptable acid addition salts. The invention also provides novel compounds of formula I-A and pharmaceutical compositions containing them. The most preferred indication is Alzheimer's disease.
    • 本发明涉及治疗选自认知障碍,焦虑,阿尔茨海默氏病和精神分裂症的疾病的方法,其包括给予治疗有效量的取代的咪唑并[1,5-a] [1,2, 4]三唑并[1,5-d] [1,4]苯并二氮杂衍生物其中R1是卤素,低级烷基,低级炔基,环烷基,低级烷氧基,OCF3,-NHR,-NHC(O) NHSO2R; R2是氢,甲基或芳基,其未被取代或被一个或两个选自卤素和低级烷氧基的取代基取代; R3是氢,低级烷基,低级烯基,环烷基,低级烷氧基,-O(CH2)n + 1-O-低级烷基, - (CH2)n-芳基,其任选被低级烷基或卤素,杂芳基,-NHR ,-N(R)2,其中每个R可以相同或不同,-NHCH 2C≡CH或吡咯烷-1-酮; R为氢,低级烷基,被卤素取代的低级烷基,杂芳基, - (CH 2)n O-低级烷基,-NH-低级烷基,环烷基或芳基,n为0,1,2或3。 和其药学上可接受的酸加成盐。 本发明还提供新颖的式I-A化合物和含有它们的药物组合物。 最优选的指征是阿尔茨海默病。
    • 65. 发明申请
    • Substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives
    • 取代的咪唑并[1,5-a] [1,2,4]三唑并[1,5-d] [1,4]苯并二氮杂衍生物
    • US20060079507A1
    • 2006-04-13
    • US11245736
    • 2005-10-07
    • Henner KnustHeinz StadlerAndrew Thomas
    • Henner KnustHeinz StadlerAndrew Thomas
    • A61K31/551C07D487/14
    • A61K31/5517C07D487/14
    • The present invention is concerned with a method of treating a disease selected from the group consisting of cognitive disorders, anxiety, Alzheimer's disease, and schizophrenia comprising administering a therapeutically effective amount of a substituted imidazo[1,5-a][1,2,4]triazolo[1,5-d][1,4]benzodiazepine derivatives of the following formula wherein R1 is halogen, lower alkyl, lower alkynyl, cycloalkyl, lower alkoxy, OCF3, —NHR, —NHC(O)R or —NHSO2R; R2 is hydrogen, methyl or aryl which is unsubstituted or substituted by one or two substituents selected from the group consisting of halogen and lower alkoxy; R3 is hydrogen, lower alkyl, lower alkenyl, cycloalkyl, lower alkoxy, —O(CH2)n+1—O-lower alkyl, —(CH2)n-aryl which is optionally substituted by lower alkyl or halogen, heteroaryl, —NHR, —N(R)2, wherein each R can be the same or different, —NHCH2C≡CH, or pyrrolidin-1-one; R is hydrogen, lower alkyl, lower alkyl substituted by halogen, heteroaryl, —(CH2)nO-lower alkyl, —NH-lower alkyl, cycloalkyl or aryl, and n is 0, 1, 2 or 3; and with their pharmaceutically acceptable acid addition salts. The invention also provides novel compounds of formula I-A and pharmaceutical compositions containing them. The most preferred indication is Alzheimer's disease.
    • 本发明涉及治疗选自认知障碍,焦虑,阿尔茨海默氏病和精神分裂症的疾病的方法,其包括给予治疗有效量的取代的咪唑并[1,5-a] [1,2, 4]具有下式的三唑并[1,5-d] [1,4]苯并二氮杂其中R 1是卤素,低级烷基,低级炔基,环烷基,低级烷氧基,OCF 3 -NHR,-NHC(O)R或-NHSO 2 R; R 2是未被取代的或被一个或两个选自卤素和低级烷氧基的取代基取代的氢,甲基或芳基; R 3是氢,低级烷基,低级烯基,环烷基,低级烷氧基,-O(CH 2 CH 2)n + 1 -O-低级 烷基, - (CH 2)n - 芳基,其任选被低级烷基或卤素取代,杂芳基,-NHR,-N(R)2 - 其中每个R可以相同或不同,-NHCH 2C≡CH或吡咯烷-1-酮; R为氢,低级烷基,被卤素取代的低级烷基,杂芳基, - (CH 2)n - 低级烷基,-NH-低级烷基,环烷基或芳基, 并且n为0,1,2或3; 和其药学上可接受的酸加成盐。 本发明还提供新颖的式I-A化合物和含有它们的药物组合物。 最优选的指征是阿尔茨海默病。